Pentasa 1 1 g Suppositories.
PDF Leaflet Revision Date: 11 October 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of mild to moderate ulcerative proctitis.
Dosage (summary)
1 suppository (1 g) daily for acute treatment; 1 suppository three times weekly for maintenance.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Use with caution; crosses placenta and excreted in breast milk.
Key Drug Interactions
- NSAIDs
- Azathioprine
- 6-mercaptopurine
- Thioguanine
- Warfarin
Contraindications
- Hypersensitivity to mesalazine
- Severe liver impairment
- Severe renal impairment
Common side effects
- Diarrhoea
- Nausea
- Abdominal pain
- Headache
- Rash
Counselling Points
- Monitor renal function regularly
- Ensure adequate fluid intake
- Report any severe skin reactions
Serious warnings
- Severe cutaneous adverse reactions
- Mesalazine-induced nephrotoxicity
- Blood dyscrasias
Important Disclaimer
The Pentasa 1 1 g Suppositories. professional information leaflet below is the property of Ferring and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
